Babich et al., 2021 - Google Patents
Study of the in vitro degradation dynamics of the encapsulated PAL enzyme preparation in model biological fluidsBabich et al., 2021
View PDF- Document ID
- 8361900320195063844
- Author
- Babich O
- Prosekov A
- Dyshlyuk L
- Publication year
- Publication venue
- IOP Conference Series: Earth and Environmental Science
External Links
Snippet
The use of PAL in the phenylketonuria treatment is hindered by the lack of well-studied mechanisms and systems of targeted transport of enzyme preparations to certain organs and tissues (brain, liver, skin, muscle and connective tissues, blood cells). It is known that as …
- 101700068660 PAL5 0 title abstract description 25
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Du et al. | A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides | |
Ebrahimnejad et al. | Survival of Lactobacillus acidophilus as probiotic bacteria using chitosan nanoparticles | |
US20050226905A1 (en) | Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection | |
EP0321481B1 (en) | Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals | |
KR20050083758A (en) | Composition exhibiting stabilised oxidation-reduction properties and method for the stabilisation thereof | |
BR0207398B1 (en) | Use of bacteria and yeast for biological detoxification of ochratoxins and zearalenons mycotoxins in food and animal feed, as well as detoxification method of said mycotoxins. | |
Deng et al. | Tea polyphenol liposomes overcome gastric mucus to treat Helicobacter pylori infection and enhance the intestinal microenvironment | |
CN104338112B (en) | A kind of preparation method of glutathione nano controlled-release capsule | |
JP2003002840A (en) | Cucumismelo extract coated and / or microencapsulated in a fat-soluble agent based on fatty substances | |
Zhang et al. | Carboxymethyl cellulose and carboxymethyl chitosan-based composite nanogel as a stable delivery vehicle for oyster peptides: Characterization, absorption and transport mechanism | |
Babich et al. | Study of the in vitro degradation dynamics of the encapsulated PAL enzyme preparation in model biological fluids | |
Cui et al. | Acute and chronic toxicity assessment of benzylpenicillin G residue in heat-treated animal food products | |
US12215360B2 (en) | Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith | |
JP2020183351A (en) | Anaerobic antioxidant composition | |
RU45270U1 (en) | DRY FORM OF BIOLOGICALLY ACTIVE ADDITIVE BASED ON ARTEMIA SALINA | |
CA3041914C (en) | Anaerobic antioxidant composition | |
WO2008068762A2 (en) | Chitosan formulation for cholesterol reduction in humans | |
RU2316978C2 (en) | Dry form of biologically active food supplement based on artemia salina maxillopod cysts (variants) | |
EP1171103B1 (en) | Inactivated microorganisms comprising substances having pharmacological activity | |
WO2021030785A1 (en) | Method for the preparation of low molecular weight porcine lympho-reticular polypeptides and formulations thereof | |
CN110339169A (en) | Coat nano vesicle preparations and its application of vitamin D and vitamin K | |
WO2025055959A1 (en) | Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith | |
CN116158534B (en) | High-load and stable protein liposome | |
RU2828677C1 (en) | Agent for dietary therapeutic alimentation | |
WO1999022768A1 (en) | Controlled release compositions comprising gellan gum gels |